122 related articles for article (PubMed ID: 590549)
21. Treatment of IUD related menorrhagia by indomethacin.
Yarkoni S; Anteby SO
Clin Exp Obstet Gynecol; 1984; 11(4):120-2. PubMed ID: 6437699
[TBL] [Abstract][Full Text] [Related]
22. Uterine cavity and the location of IUDs following administration of meclofenamic acid to menorrhagic women. A pilot study.
Pizarro E; Schöenstedt G; Mehech G; Hidalgo M; Romero C; Muñoz G
Contraception; 1989 Oct; 40(4):413-23. PubMed ID: 2582768
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study.
Mercorio F; De Simone R; Di Carlo C; Bifulco G; Tessitore G; Di Spiezio Sardo A; Nappi C
Hum Reprod; 2003 Nov; 18(11):2319-22. PubMed ID: 14585881
[TBL] [Abstract][Full Text] [Related]
24. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report.
Agnelli G; Gresele P; De Cunto M; Gallai V; Nenci GG
Br J Obstet Gynaecol; 1982 Aug; 89(8):681-2. PubMed ID: 7104262
[TBL] [Abstract][Full Text] [Related]
25. Hysterography and the IUD.
Reiertsen O; Eyjolfsson O
Contracept Deliv Syst; 1980 Oct; 1(4):389-98. PubMed ID: 12262142
[TBL] [Abstract][Full Text] [Related]
26. Editorial: IUDs and heavy periods.
Br Med J; 1976 Feb; 1(6005):304. PubMed ID: 1247833
[TBL] [Abstract][Full Text] [Related]
27. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen).
Roy S; Shaw ST
Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136
[TBL] [Abstract][Full Text] [Related]
28. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
Sheppard BL; Bonnar J
Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
[TBL] [Abstract][Full Text] [Related]
29. [Local proteinase inhibitor concentration in uterine secretions with intrauterine spirals (IUD) in situ (proceedings)].
Tauber PF; Herting W; Kurz E; Feichter GE
Arch Gynakol; 1977 Jul; 224(1-4):32-3. PubMed ID: 579835
[TBL] [Abstract][Full Text] [Related]
30. Tranexamic acid: a review of its use in the management of menorrhagia.
Wellington K; Wagstaff AJ
Drugs; 2003; 63(13):1417-33. PubMed ID: 12825966
[TBL] [Abstract][Full Text] [Related]
31. The effect of vitamin B1 on bleeding and spotting in women using an intrauterine device: a double-blind randomised controlled trial.
Jafari A; Abedi P; Sayahi M; Torkashvand R
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):180-6. PubMed ID: 24738933
[TBL] [Abstract][Full Text] [Related]
32. Menstrual blood loss of TCu-380 A and TCu-200 B IUDs.
El-sheikha Z; Hamza A; Mahmoud M
Popul Sci; 1990 Jul; ():55-62. PubMed ID: 12343358
[TBL] [Abstract][Full Text] [Related]
33. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
[TBL] [Abstract][Full Text] [Related]
34. [Clinical aspects of contraception by means of copper-7 and copper-T intrauterine devices].
Peksa A; Sternadel Z
Ginekol Pol; 1978 Sep; 49(9):781-5. PubMed ID: 730064
[TBL] [Abstract][Full Text] [Related]
35. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
[TBL] [Abstract][Full Text] [Related]
36. [The acceptability of current contraceptive methods to adolescents].
Sotnikova EI; Dubnitskaia LV; Perminova SG
Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
[TBL] [Abstract][Full Text] [Related]
37. The use of intrauterine contraceptive devices in diabetics.
Craig GM
Br J Sex Med; 1982 Feb; 9():44-8. PubMed ID: 12279278
[TBL] [Abstract][Full Text] [Related]
38. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception].
Monteil-seurin J; Bernard-fernier MF; Martinaggi P; Demarez JP; Cauquil J; Lafont A
Contracept Fertil Sex (Paris); 1985 May; 13(5):721-5. PubMed ID: 12267101
[TBL] [Abstract][Full Text] [Related]
40. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
